These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 30718561

  • 21. Diagnostic accuracy of 64-slice multidetector CT angiography for detection of in-stent restenosis of vertebral artery ostium stents: comparison with conventional angiography.
    Lee YJ, Lim YS, Lim HW, Yoo WJ, Choi BG, Kim BS.
    Acta Radiol; 2014 Oct; 55(8):1000-7. PubMed ID: 24107930
    [Abstract] [Full Text] [Related]

  • 22. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E, Mut-Vitcu B, Tanaseanu GR, Marta DS, Manea G, Kosaka T, Vidulescu C, Tanaseanu C.
    Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
    [Abstract] [Full Text] [Related]

  • 23. Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation.
    Yuan Y, Liu X, Hao S, He Q, Shen Z.
    Ann Transl Med; 2020 Jun; 8(12):756. PubMed ID: 32647681
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O, Canpolat U, Özcan F, Mendi MA, Oksüz F, Işleyen A, Gürel OM, Çay S, Aras D, Aydoğdu S.
    Am J Cardiol; 2014 Jan 15; 113(2):197-202. PubMed ID: 24157191
    [Abstract] [Full Text] [Related]

  • 25. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ, Melbourne Interventional Group (MIG) Investigators.
    Heart Lung Circ; 2007 Aug 15; 16(4):269-73. PubMed ID: 17419097
    [Abstract] [Full Text] [Related]

  • 26. Impaired Peripheral Endothelial Function Assessed by Digital Reactive Hyperemia Peripheral Arterial Tonometry and Risk of In-Stent Restenosis.
    Komura N, Tsujita K, Yamanaga K, Sakamoto K, Kaikita K, Hokimoto S, Iwashita S, Miyazaki T, Akasaka T, Arima Y, Yamamoto E, Izumiya Y, Yamamuro M, Kojima S, Tayama S, Sugiyama S, Matsui K, Nakamura S, Hibi K, Kimura K, Umemura S, Ogawa H.
    J Am Heart Assoc; 2016 Jun 17; 5(6):. PubMed ID: 27317348
    [Abstract] [Full Text] [Related]

  • 27. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
    Wu XA, Xie G, Li XQ, Wu HT, Wang X.
    Clin Chim Acta; 2018 Apr 17; 479():20-24. PubMed ID: 29305846
    [Abstract] [Full Text] [Related]

  • 28. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X, Pandit RU, Han L, Li Y, Guo X.
    Angiology; 2019 Oct 17; 70(9):853-859. PubMed ID: 31167539
    [Abstract] [Full Text] [Related]

  • 29. Combination of Circulating miRNA-320a/b and D-Dimer Improves Diagnostic Accuracy in Deep Vein Thrombosis Patients.
    Jiang Z, Ma J, Wang Q, Wu F, Ping J, Ming L.
    Med Sci Monit; 2018 Apr 06; 24():2031-2037. PubMed ID: 29622762
    [Abstract] [Full Text] [Related]

  • 30. CHA2DS2-Vasc score and CHA2DS2-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents.
    Zhao SG, Xu JJ, Tao ZH, Jin L, Liu Q, Zheng WY, Jiang LQ, Wang NF.
    J Int Med Res; 2019 Jun 06; 47(6):2533-2544. PubMed ID: 31039653
    [Abstract] [Full Text] [Related]

  • 31. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.
    Chin Med J (Engl); 2013 Mar 06; 126(6):1019-25. PubMed ID: 23506572
    [Abstract] [Full Text] [Related]

  • 32. The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting.
    Hajizadeh R, Ghaffari S, Separham A, Shokouhi B, Kavandi H, Pourafkari L, Nader ND.
    Rom J Intern Med; 2017 Dec 01; 55(4):229-236. PubMed ID: 28672766
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic value of magnetocardiography in patients with coronary heart disease and in-stent restenosis.
    Quan WW, Lu GP, Qi WH, Li YM, Shen Y, Yuan R.
    Chin Med J (Engl); 2008 Jan 05; 121(1):22-6. PubMed ID: 18208660
    [Abstract] [Full Text] [Related]

  • 34. The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.
    Yang Y, Ge F, Shen J, Song J, Xie J, Qu J, Mao X, Kuang Z, Wang X, Wu Y, Wang S, Xiao L.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32583853
    [Abstract] [Full Text] [Related]

  • 35. Roles of MicroRNAs in Peripheral Artery In-Stent Restenosis after Endovascular Treatment.
    Wang M, Zhang W, Zhang L, Wang L, Li J, Shu C, Li X.
    Biomed Res Int; 2021 Jul 31; 2021():9935671. PubMed ID: 34368362
    [Abstract] [Full Text] [Related]

  • 36. Association of serum procalcitonin level with in-stent restenosis in patients undergoing bare-metal stent implantation.
    Ornek E, Cetin M, Kiziltunc E, Kurtul A, Gok M, Kundi H.
    Biomark Med; 2018 May 31; 12(5):455-463. PubMed ID: 29517279
    [Abstract] [Full Text] [Related]

  • 37. Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis.
    Jones GT, Tarr GP, Phillips LV, Wilkins GT, van Rij AM, Williams MJ.
    Atherosclerosis; 2009 Dec 31; 207(2):603-7. PubMed ID: 19576586
    [Abstract] [Full Text] [Related]

  • 38. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.
    JACC Cardiovasc Interv; 2009 Dec 31; 2(12):1269-75. PubMed ID: 20129555
    [Abstract] [Full Text] [Related]

  • 39. Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography.
    Wan YL, Tsay PK, Chen CC, Juan YH, Huang YC, Chan WH, Wen MS, Hsieh IC.
    Int J Cardiovasc Imaging; 2016 Jun 31; 32 Suppl 1():105-15. PubMed ID: 27106698
    [Abstract] [Full Text] [Related]

  • 40. Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention.
    Liu J, Liu Y, Jia K, Huo Z, Huo Q, Liu Z, Li Y, Han X, Wang R.
    Medicine (Baltimore); 2018 Apr 31; 97(17):e0366. PubMed ID: 29702981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.